Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Pfizer’s COVID pill reportedly offered no measurable benefit for adults 40 to 65, according to a study published on Wednesday.

The Israeli study was conducted among 109,000 patients who were 40 years old or older.

READ MORE
 

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

U.S. Nuclear Force Modernization Must Happen

The race towards modern nuclear warfare is in full force,…
Read more

Submit Sermons to Government?

Preachers in Denmark are coming to the realization that they…
Read more

U.S. to Rejoin UN Human Rights Council

Since taking office, President Biden has been undoing many…
Read more